Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stability of hepatitis E virus at high hydrostatic pressure processing.
Johne R, Wolff A, Gadicherla AK, Filter M, Schlüter O. Johne R, et al. Among authors: wolff a. Int J Food Microbiol. 2021 Feb 2;339:109013. doi: 10.1016/j.ijfoodmicro.2020.109013. Epub 2020 Dec 13. Int J Food Microbiol. 2021. PMID: 33340943 Free article.
Stability of hepatitis E virus at different pH values.
Wolff A, Günther T, Albert T, Schilling-Loeffler K, Gadicherla AK, Johne R. Wolff A, et al. Int J Food Microbiol. 2020 Jul 16;325:108625. doi: 10.1016/j.ijfoodmicro.2020.108625. Epub 2020 Apr 18. Int J Food Microbiol. 2020. PMID: 32361052
Valence ambiguity dynamically shapes striatal dopamine heterogeneity.
Bornhoft KN, Prohofsky J, O'Neal TJ, Wolff AR, Saunders BT. Bornhoft KN, et al. Among authors: wolff ar. bioRxiv [Preprint]. 2024 May 17:2024.05.17.594692. doi: 10.1101/2024.05.17.594692. bioRxiv. 2024. PMID: 38798567 Free PMC article. Preprint.
Risk Stratification with Sarculator and MSKCC in Patients with Primary and Secondary Angiosarcoma.
Steubing Y, Ahmadi N, Puscz F, Wolff A, Hinzmann J, Reinkemeier F, Schmidt SV, Sogorski A, Von Glinski M, Becerikli M, Füth M, Zuchowski J, Brüggenhorst H, Huyghebaert T, Stricker I, Lehnhardt M, Wallner C. Steubing Y, et al. Among authors: wolff a. Life (Basel). 2024 Apr 28;14(5):569. doi: 10.3390/life14050569. Life (Basel). 2024. PMID: 38792591 Free PMC article.
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.
Freedman RA, Caswell-Jin JL, Hassett M, Somerfield MR, Giordano SH; Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer Guideline Expert Panel. Freedman RA, et al. J Clin Oncol. 2024 May 20:JCO2400886. doi: 10.1200/JCO.24.00886. Online ahead of print. J Clin Oncol. 2024. PMID: 38768407
A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).
Mezzanotte-Sharpe J, ONeill A, Mayer IA, Arteaga CL, Yang XJ, Wagner LI, Cella D, Meropol NJ, Alpaugh RK, Saphner TJ, Swaney RE, Hoelzer KL, Gradishar WJ, Abramson VG, Sundaram PK, Jilani SZ, Perez EA, Lin NU, Jahanzeb M, Wolff AC, Sledge GW, Reid SA. Mezzanotte-Sharpe J, et al. Among authors: wolff ac. Res Sq [Preprint]. 2024 Apr 29:rs.3.rs-4295044. doi: 10.21203/rs.3.rs-4295044/v1. Res Sq. 2024. PMID: 38746356 Free PMC article. Preprint.
1,342 results